Biogen/ US09062X1037 /
| 6/20/2025 9:59:55 PM | Chg. +0.44 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 127.06USD | +0.35% | 49,102 Turnover: 6.23 mill. |
-Bid Size: - | -Ask Size: - | 18.61 bill.USD | - | 11.33 |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 11.21 USD | 39.78% |
| EPS Diluted: | 11.18 USD | 40.28% |
| Revenues per Share: | 66.10 USD | -2.31% |
| Book Value per Share: | 114.20 USD | 12.17% |
| Cash Flow per Share: | 19.64 USD | 84.56% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 9,675.90 USD | -1.62% |
| Net Income: | 1,632.20 USD | 40.57% |
| Operating Cash Flow: | 2,875.50 USD | - |
| Cash and Cash Equivalents: | 2,375.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 11.33 | 13.64 |
| P/S Ratio: | 1.92 | 2.31 |
| P/BV ratio: | 1.11 | 1.34 |
| P/CF Ratio: | 6.47 | 7.78 |
| PEG: | 0.28 | 0.34 |
| Earnings Yield: | 8.82% | 7.33% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 18.61 bill. USD | 22.38 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 146.53 mill. | |
Profitability
| Gross Profit Margin: | 76.12% |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 16.87% |
| Return on Equity: | 9.76% |
| Return on Assets: | 5.82% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.43% |
| Liquidity II / Quick Ratio: | 0.68% |
| Liquidity III / Current Ratio: | 1.35% |
| Debt / Equity Ratio: | 0.38% |
| Dynam. Debt / Equity Ratio: | 394.13% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2024 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
